INS and Hyperglycemia: In GDM, hyperglycaemia impairs the ability of β‐cells to sense glucose and release insulin (β‐cell dysfunction), leading to a progressive failure to compensate for peripheral insulin resistance, which in turn worsens hyperglycaemia.